88641502 - CC CELULARITY

Information

• Trademark
• 88641502

• Source

• Serial Number

  88641502

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  October 03, 2019
  5 years ago

• Transaction Date

  June 01, 2021
  3 years ago

• Status Date

  May 31, 2021
  3 years ago

• Published for Opposition Date

  March 03, 2020
  4 years ago

• Location Date

  April 28, 2020
  4 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  SINGH, TEJBIR

• Attorney Docket Number

  CLTY-0002US/

  Attorney Name

  Camille M. Miller

  Law Office Assigned Location Code

  L60

• Owners

  • Celularity, Inc.

Case File Statements

• CC0000: The color(s) teal, blue, purple, lilac and grey is/are claimed as a feature of the mark.
• DM0000: The mark consists of two "CC's" intersecting in the middle with the tips of the "C's" in teal blending to blue as moving toward the center of the "C's" blending to purple as continue to move toward the middle of the "C's" and intersecting at lilac and then blending back to purple and then blue and then to teal as proceed to other end of the "C's", and to the left of the intersection of the "C's" is the word "CELULARITY" in grey.
• GS0011: Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
• GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
• GS0421: Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Case File Event Statements

• 6/1/2021 - 3 years ago

  24 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/31/2021 - 3 years ago

  23 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 10/21/2020 - 4 years ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/19/2020 - 4 years ago

  21 - EXTENSION 1 GRANTED Type: EX1G

• 10/19/2020 - 4 years ago

  20 - EXTENSION 1 FILED Type: EXT1

• 10/19/2020 - 4 years ago

  19 - TEAS EXTENSION RECEIVED Type: EEXT

• 10/8/2020 - 4 years ago

  18 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/8/2020 - 4 years ago

  17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/8/2020 - 4 years ago

  16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 4/28/2020 - 4 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/3/2020 - 4 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/3/2020 - 4 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/12/2020 - 4 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/24/2020 - 4 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/23/2020 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/23/2020 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/21/2020 - 4 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 1/9/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/8/2020 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/8/2020 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/8/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/8/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/9/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 10/7/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP